MissionIR Articles

Founded in 2005, biopharmaceutical company CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD) is focused on developing small molecules for the acute treatment of migraine headaches. The company’s lead product candidates are oral lasmiditan, an oral tablet for…

Codexis, Inc. (NASDAQ: CDXS) provides unique, state-of-the-art enzyme optimization services and developing biocatalyst products. The company’s technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients (APIs), fine chemicals, agrochemicals, food ingredients, detergents and…

Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is a cleantech emissions control company that designs, develops and manufactures sustainable solutions to reduce emissions of on- and off-road engine applications. Within its sector, the company is a…

Cipher Pharmaceuticals, Inc. (NASDAQ: CPHR) is a dermatology company committed to offering healthcare professionals products that will better address their patients’ needs and enrich their practices. As such, the company’s innovative dermatology products provide efficacy,…

China XD Plastics Company Ltd. (NASDAQ: CXDC) engages in researching, developing, manufacturing and selling modified plastics primarily for automotive applications in China and Dubai, the United Arab Emirates. The company’s modified plastics are used to…

China Recycling Energy Corp. (NASDAQ: CREG) designs, finances, constructs, operates and transfers waste energy recycling projects to mid- to large-size enterprises involved in high energy-consuming businesses. The company offers waste pressure to energy systems, including…

China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), through its own retail drugstores, wholesale distributor and online pharmacy, is a retailer and wholesale distributor of pharmaceutical and healthcare products in China. As of March 31, 2015, the…

China Energy Technology Corp., Ltd. (OTC: CETH) designs, manufactures, and sells solar water heaters and related solar products. The company offers vacuum tube solar energy collector, as well as the balcony flat panel solar energy…

ChemoCentryx, Inc. (NASDAQ: CCXI) is a biopharmaceutical company that specializes in creating orally administered new medicines that inhibit chemo-attractant receptors – the engines of cell migration in disease. The company focuses exclusively on discovering, developing…

Chembio Diagnostics, Inc. (NASDAQ: CEMI) is committed to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). At the core of its commitment is its patented Next…

Check-Cap Ltd. (NASDAQ: CHEK) is a clinical stage medical diagnostics company leading the development of the first ingestible imaging capsule that utilizes low-dose X-rays for CRC screening. The Check-Cap device requires no bowel preparation or…

Cesca Therapeutics Inc. (NASDAQ: KOOL) is focused on three target markets: cellular therapeutics; medical/diagnostic device development and commercialization; and cell manufacturing and banking. Cesca’s lead therapeutic technology platform, SurgWerks (an intraoperative rapid system for harvesting,…

Cerulean Pharma, Inc. (NASDAQ: CERU) is focused on making nanoparticle-drug conjugates (NDCs) designed to target rumors, reduce toxicity and enable combinations. The Cerulean team is committed to developing products to improve treatment options for people…

Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company, is focused on developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies. The company’s lead program is ThermoDox, a proprietary heat-activated…

Cellectar Biosciences, Inc. (NASDAQ: CLRB) is developing agents to detect, treat and monitor a broad spectrum of cancers. With the ability to attach imaging and therapeutic agents to its proprietary delivery platform – a novel…

Celator Pharmaceuticals, Inc. (NASDAQ: CPXX) is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer. Celator’s proprietary technology platform, CombiPlex, enables the rational…

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. Catalyst is developing Firdapse (Amifampridine Phosphate, or 3,4-diaminopyridine phosphate) for the treatment of…

Catalyst Biosciences, Inc. (NASDAQ: CBIO) is a clinical-stage biopharmaceutical company focused on creating and developing novel medicines to address serious medical conditions in the fields of hemostasis. Catalyst’s most advanced program, an improved next-generation coagulation…

CASI Pharmaceuticals, Inc. (NASDAQ: CASI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of therapeutics addressing cancer and other unmet medical needs. Part of its strategy is to leverage its expertise and…

Cardiome Pharma Corp. (NASDAQ: CRME) is an integrated, commercial, specialty pharmaceutical company dedicated to the development and commercialization of new therapies that will improve the health and quality of life of patients. The company strives…